Related Experiment Video
Updated: Apr 30, 2026

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
Published on: December 23, 2022
PLCE1 suppresses p53 expression in esophageal cancer cells
Yun Li1, Jun An, Shaohong Huang
1Department of Cardiothoracic Surgery, The Third Affiliated Hospital of Sun Yat-sen University , Guangzhou , China.
Abstract:
The apoptotic mechanism dysfunction plays a critical role in cancer cell growth and escaping from cancer therapies; the underlying mechanisms are to be further elucidated. This study aims to investigate the role of phospholipase C epsilon 1 (PLCE1) in modulating the apoptosis mechanism in esophageal cancer (Eca) cells. The results showed that Eca cell lines, OE33 and CP-C cells expressed high levels of PLCE1. Knockdown of PLCE1 markedly increased 9.26 folds of the expression of p53 and 13.8 folds of the frequency of apoptotic CP-C cells via modulating the p53 promoter methylation.
Insights
Phospholipase C epsilon 1 (PLCE1) knockdown enhances apoptosis in esophageal cancer cells by increasing p53 expression. This suggests PLCE1 is a potential therapeutic target for esophageal cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Dysregulation of apoptosis is crucial for cancer cell proliferation and therapeutic resistance.
- Understanding the molecular mechanisms governing apoptosis is essential for developing effective cancer treatments.
Purpose of the Study:
- To investigate the role of phospholipase C epsilon 1 (PLCE1) in regulating apoptosis in esophageal cancer (Eca) cells.
- To elucidate the specific mechanisms by which PLCE1 influences cancer cell death pathways.
Main Methods:
- Expression analysis of PLCE1 in esophageal cancer cell lines (OE33 and CP-C).
- Experimental knockdown of PLCE1 in Eca cells.
- Assessment of p53 expression levels and apoptotic cell frequency.
- Analysis of p53 promoter methylation.
Main Results:
- Esophageal cancer cell lines OE33 and CP-C exhibited high PLCE1 expression.
- PLCE1 knockdown significantly upregulated p53 expression (9.26-fold increase).
- Knockdown of PLCE1 markedly increased the frequency of apoptotic CP-C cells (13.8-fold increase) through p53 promoter methylation modulation.
Conclusions:
- PLCE1 plays a significant role in suppressing apoptosis in esophageal cancer.
- Modulating PLCE1 expression, potentially via p53 promoter methylation, offers a novel therapeutic strategy for esophageal cancer.
Related Concept Videos
Abnormal Proliferation
Cell Specific Gene Expression
Induced Pluripotent Stem Cells
Somatic...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Mitogens and the Cell Cycle
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

